Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New adrenal-scanning agent.

M Kojima, M Maeda, H Ogawa

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment.

    Pediatric dermatology·1992
    Same author

    Stimulation of keratinocyte migration by growth factors.

    The Journal of dermatology·1992
    Same author

    A wound healing model using healing-impaired diabetic mice.

    The Journal of dermatology·1992
    Same author

    The response to drug therapy in unstable angina on the basis of coronary angiography findings.

    Japanese circulation journal·1992
    Same author

    [The pathogenic role of Chlamydia trachomatis in otitis media with effusion].

    Nihon Jibiinkoka Gakkai kaiho·1992
    Same author

    [Prospective randomized trials comparing hyperfractionated radiotherapy with conventional radiotherapy in stage III non-small cell lung cancer].

    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
    Same journal

    Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    Erratum.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    Live from 2026 SNMMI Annual Meeting in Los Angeles!

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    Same journal

    CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
    See all related articles

    A novel adrenal-specific compound, 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol (NCL-3-I), shows superior accumulation in rat adrenal glands compared to its precursor. This makes NCL-3-I a promising candidate for adrenal imaging.

    Area of Science:

    • Endocrinology
    • Radiochemistry
    • Nuclear Medicine

    Background:

    • Development of targeted radiotracers is crucial for accurate diagnostic imaging.
    • Cholesterol derivatives have been explored for their potential in imaging adrenal function.

    Purpose of the Study:

    • To introduce and evaluate a new cholesterol-derived compound, 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol (NCL-3-I), as a potential adrenal-specific imaging agent.

    Main Methods:

    • Synthesis of NCL-3-I from 19-iodocholesterol (CL-19-I).
    • Tissue distribution studies in rats using radiolabeled NCL-3-I and CL-19-I.

    Main Results:

    • Rat adrenal glands accumulated ten times more radiolabeled NCL-3-I (NCL-6-131-I) compared to radiolabeled CL-19-I (CL-19-131-I).

    Related Experiment Videos

  • Demonstrated adrenal specificity of the NCL-3-I compound.

    • Conclusions:

    • NCL-3-I exhibits enhanced adrenal gland uptake, suggesting its potential as a superior adrenal-scanning agent.
    • Further investigation into NCL-3-I is warranted for its clinical application in adrenal imaging.